Sr. Director, Global Market Access Lead - Early Portfolio, Cell & Gene Therapy

Bayer•Cambridge, MA

14h•Hybrid

About The Position

The Sr. Director, Global Market Access Lead - Early Portfolio, Cell & Gene Therapy will play a pivotal role in designing and executing market access strategies for Bayer's early portfolio, with a strong focus on cell & gene therapies. Reporting to the Head of Early Access / Cell and Gene Therapy (CGT), this position is critical within the organization. The role's efforts will optimize price, reimbursement, and access speed through coordinated payer insights, evidence planning, and value communication. The individual will align market access strategies with brand vision, de-risk long-term business plans, and enhance brand value through comprehensive strategies that drive efficiencies in Health Technology Assessment (HTA) and market access operations. The location for this role is Whippany, NJ or Cambridge, MA, but other locations, including Basel and Berlin, will be considered on a case by case basis.

Requirements

Advanced degree (PharmD, PhD, MD, MSc, MBA) or equivalent experience in life sciences, health economics, public health, or business
Expertise in Market Access with a track record of successful submissions and negotiations
Strong commercial acumen with experience in pricing strategy and innovative payment models
Experience in the US market and strong leadership skills in a matrix structure
Ability to create an ambitious vision based on deep insights into payer needs
Track record for re-imagining market access challenges and creating opportunities
Proactively identifies organizational barriers and builds diverse teams and networks

Nice To Haves

Minimum 10–12 years’ experience in pharmaceutical/biotech market access with progressive leadership responsibility
Experience in rare/orphan disease and small patient populations
Familiarity with outcomes-based or annuity payment models for cell & gene therapies
Familiarity with major EU HTA bodies and US payer systems
Prior inpatient ICD and DRG experience in the U.S. or any maor global market highly desireable
Deep understanding of hospital access, infrastructure, procurement, contracting, coverage, and adoption highly desirable
Prior launch experience
Prior Neurology and / or CGT or CAR-T experience
Prior health policy and / or stakeholder advocacy experience

Responsibilities

Lead the development and implementation of global market access strategies for early portfolio and cell & gene therapy programs
Builds comprehensive market access strategy and plan for an inpatient modality, supported by clear stakeholder mapping, and an understanding of key decision makers in coding, coverage, reimbursement and the overall value chain in cell therapy procurement and adoption
Define launch sequencing, access roadmaps, and prioritization by geography
Design and oversee payer-facing evidence generation, including value dossiers and economic models
Work and lead projects cross-functionally, including with partner organizations and vendors
Lead pricing strategy and innovative contracting design for therapies
Prepare reimbursement deliverables and ensure consistency between scientific evidence and economic modeling
Form and maintain stakeholder interractions both internally and externally
Lead cross-functional teams to ensure access considerations drive development decisions
Manage external vendors and consultants to deliver high-quality access deliverables
Provide leadership and mentorship for the access team
Track and report access outcomes and manage access-related budgets
Represent the company in external forums and HTA engagements
Act as Visionary, Architect, Catalyst, and Coach in shaping the GMACS outcome-setting process